Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis

Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis

Patients with chronic virus hepatitis (32 patients, 13 with chronic hepatitis B and 19 with chronic hepatitis C) ages from 20 to 72 with elevated levels of bilirubin and active alanine aminotransferase, aspartate aminotransferase, gamma- glutamyl transpeptidase, received ursodeoxycholic acid (Urdoxa...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Esaulenko, O. E. Nikitina, N. V. Dunaeva, A. N. Uskov, T. L. Mogilevets
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	chronic viral hepatitis ursodeoxycholic acid urdoxa
Online Access:	https://journal.niidi.ru/jofin/article/view/39
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study
by: Ethan Weinberg, et al.
Published: (2024-07-01)

Ursodeoxycholic acid and hepatic diseases
by: G. V. Volynets, et al.
Published: (2021-06-01)

CHOLESTASIS IN ACUTE AND CHRONIC VIRAL HEPATITIS
by: V. F. Uchaikin, et al.
Published: (2015-08-01)

Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid
by: Hasan Naz, et al.
Published: (2009-09-01)

Viral load in chronic hepatitis b: correlation with laboratory and morphological parameters
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid
by: Sevim Çakar, et al.
Published: (2024-12-01)

Effect of Ursodeoxycholic Acid Alone Verses Ursodeoxycholic Acid and Rifampicin in Obstetric Cholestasis
by: Ayesha Amjad, et al.
Published: (2025-07-01)

Ursodeoxycholic acid therapy in children with cholestatic liver disease
by: Gönül Dinler, et al.
Published: (1999-01-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Viral hepatitis
by: D. Brink
Published: (2006-09-01)

Studies on the Synthesis Process of Plant-Derived Ursodeoxycholic Acid Intermediates
by: Shaoxiong Jing, et al.
Published: (2025-03-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)

Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2020-06-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model
by: Ali Seven, et al.
Published: (2023-11-01)

Ursodeoxycholic acid preparations in the complex treatment of non-alcoholic fatty liver disease and diabetes mellitus
by: U. A. Khalilova, et al.
Published: (2023-06-01)

The Impact of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Infants Treated with Photo-therapy: A Single-Blind Randomized Clinical Trial
by: Mohammad Sobhani Shahmirzadi, et al.
Published: (2024-10-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
by: S. B. Chuelov, et al.
Published: (2017-09-01)

Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
by: Olesya V. Zakharova
Published: (2024-05-01)

Viral hepatitis in children: state and prospects for solving the problem
by: L. G. Goriacheva, et al.
Published: (2021-12-01)

Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment
by: Xuxuan Gao, et al.
Published: (2025-05-01)

Cardiac hemodynamic disorders in patients with active chronic viral hepatitis and the effectiveness of antiviral therapy
by: M. V. Chistyakova, et al.
Published: (2020-12-01)

Non-alcoholic fatty liver disease: a heterogeneous phenotype. Pleiotropic effects of ursodeoxycholic acid
by: E. A. Ljaljukova
Published: (2023-08-01)

The prevalence of viral hepatitis D in the world
by: V. G. Akimkin, et al.
Published: (2022-07-01)

Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

THE DRUG-INDUCED HEPATITIS IN CHILDREN
by: O. V. Molochkova, et al.
Published: (2017-03-01)

The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial
by: Yilihamu Abulitifu, et al.
Published: (2025-07-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

Efficiency and safety of application of combined scheme with ursodeoxycholic acid and mebeverin preparations in patients with metabolic syndrome
by: Yu. P. Uspensky, et al.
Published: (2021-06-01)

Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis
by: M. V. Chistyakova, et al.
Published: (2019-07-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Chronic viral hepatitis B and D in pregnant women: course and outcomes (review)
by: M. D. Akhmedova, et al.
Published: (2021-07-01)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Viral hepatitis B epidemiology in Sakha republic (Yakutia)
by: S. I. Semenov, et al.
Published: (2015-09-01)

Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models
by: Patrik Kovács, et al.
Published: (2024-12-01)